Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Shanley
Reduced-Intensity Hematopoietic Cell Transplantation in Older Patients With AML/MDS: Umbilical Cord Blood Is a Feasible Option for Patients Without HLA-matched Sibling Donors
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes: Comparable Outcomes With Unrelated Umbilical Cord Blood and HLA-Identical Sibling Donors
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning Without Antithymocyte Globulin in Adult Patients With Severe Aplastic Anemia
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Prognostic Value of the Hematopoietic Cell Transplantation Comorbidity Index for Patients Undergoing Reduced-Intensity Conditioning Cord Blood Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
High-Resolution HLA Matching in Double-Umbilical-Cord-Blood Reduced-Intensity Transplantation in Adults
Transfusion
Allergy
Immunology
Hematology
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab From HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients With Hematologic Malignancies
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS
Bone Marrow Transplantation
Transplantation
Hematology
Allogeneic Blood Cell Transplantation Following Reduced-Intensity Conditioning Is Effective Therapy for Older Patients With Myelofibrosis With Myeloid Metaplasia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Umbilical Cord Blood Stem Cell Transplantation From Unrelated HLA-matched Donor in an Infant With Severe Congenital Neutropenia
Bone Marrow Transplantation
Transplantation
Hematology
